Preclinical studies cdn_helper

Robust validation studies suggest potent clinical efficacy

Engineered SRC-3 KO Treg cells have been stress tested in various conditions:

  • Studied in a broad range of aggressive solid tumors
  • Effective in preventing growth of tumors
  • Effective in eradicating established tumors
  • Dose response studies further validate therapy

Proven effective in:

Triple Negative Breast Cancer

Prostate Cancer

Glioblastoma

Pancreatic Cancer

Lung Cancer

Impressive and consistent
preclinical efficacy

  • Eradication of aggressive cancer cells
  • No cancer recurrence
  • Does not inhibit critical functions
  • Nontoxic and no inflammation
  • No off target effects
  • Rapid treatment results
  • Normal animal reproduction
  • Normal litters
  • Live full lifespan
Close

Franklyn Prendergast, MD, PhD